Drug class
Beta-lactamase inhibitor; component of cefepime/enmetazobactam antibacterial combination
Mechanism of action
Inhibits class A beta-lactamases, including extended-spectrum beta-lactamases (ESBLs), protecting cefepime from hydrolysis and restoring antibacterial activity against susceptible Gram-negative organisms.
General use cases
- Component of the fixed combination cefepime/enmetazobactam (EXBLIFEP) for adults with complicated urinary-tract infections, including pyelonephritis, caused by susceptible Gram-negative bacteria; not a standalone antibiotic indication
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
